VARISITE
Live / Registered — Registered (as of 24 Feb 2026)
What this means for you
Registered since 24 Feb 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 24 Feb 2032: the §8 declaration of use).
Record
- Serial number
- 97473339
- Registration number
- 8152255
- Mark type
- Word mark
- Filed
- 23 Jun 2022
- Published for opposition
- 21 Nov 2023
- Registered
- 24 Feb 2026
- Next maintenance filing
- §8 declaration of use, due by 24 Feb 2032 (grace period to 24 Aug 2032)
- Attorney of record
- ANNE E. NAFFZIGER
Goods and services
- Class 005 — Pharmaceuticals: Wound dressings, namely, adhesive wound dressings exclusively for external use
Owner
- Sessions Pharmaceuticals Inc., Fort Worth, TX, US
- Sessions Pharmaceuticals Inc., Fort Worth, TX, US
- Sessions Pharmaceuticals Inc., Fort Worth, TX, US
Board proceedings on this mark
- Opposition No. 91290412 — Covidien LP v. Sessions Pharmaceuticals Inc., filed 19 Mar 2024 (Terminated)
- Extension of Time to Oppose No. 97473339 — COVIDIEN LP v. Sessions Pharmaceuticals Inc., filed 19 Dec 2023 (Terminated)
Prosecution history
- 24 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 05 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Aug 2025 — USE AMENDMENT FILED
- 06 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 05 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Jun 2025 — TTAB RELEASE CASE TO TRADEMARKS
- 27 Jun 2025 — OPPOSITION TERMINATED NO. 999999
- 27 Jun 2025 — OPPOSITION DISMISSED NO. 999999
- 20 Mar 2024 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 19 Mar 2024 — OPPOSITION INSTITUTED NO. 999999
- 19 Dec 2023 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 21 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED